tiprankstipranks
Evofem Biosciences (EVFM)
OTHER OTC:EVFM
US Market
Holding EVFM?
Track your performance easily

Evofem Biosciences (EVFM) Financial Statements

1,217 Followers

Evofem Biosciences Financial Overview

Evofem Biosciences's market cap is currently ―. The company's EPS TTM is $-0.909; its P/E ratio is -0.01; Evofem Biosciences is scheduled to report earnings on May 7, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 4.50M$ 4.16M$ 4.84M$ 5.11M$ 2.46M
Gross Profit$ 3.63M$ 3.39M$ 3.88M$ 3.22M$ 165.00K
EBIT$ -1.82M$ 1.91M$ -3.38M$ -3.55M$ -7.99M
EBITDA$ -1.52M$ 1.95M$ -2.05M$ -3.52M$ -7.08M
Net Income Common Stockholders$ -2.37M$ 1.30M$ -5.10M$ 66.00M$ -8.56M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Total Assets$ 23.94M$ 8.55M$ 10.55M$ 13.32M$ 14.07M
Total Debt$ 394.00K$ 511.00K$ 43.37M$ 41.23M$ 43.20M
Net Debt$ 394.00K$ 511.00K$ 43.37M$ 41.23M$ 43.20M
Total Liabilities$ 90.07M$ 73.18M$ 77.06M$ 67.88M$ 69.74M
Stockholders Equity$ -70.89M$ -69.31M$ -66.51M$ -56.36M$ -55.66M
Cash Flow-
Free Cash Flow$ -459.00K$ -1.14M$ -170.00K$ -2.36M$ -1.50M
Operating Cash Flow$ -459.00K$ -1.14M$ -170.00K$ -2.36M$ -1.49M
Investing Cash Flow$ -509.00K---$ -1.00K
Financing Cash Flow$ 998.00K$ 1.14M$ 340.00K$ 2.14M$ 597.00K
Currency in USD

Evofem Biosciences Earnings and Revenue History

Evofem Biosciences Debt to Assets

Evofem Biosciences Cash Flow

Evofem Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis